RXO Inc at Barclays Industrial Select Conference Transcript
Okay.
There we go. I guess we're live. Well, good morning or almost good afternoon here. Welcome to day two of Barclays Industrial Select Conference. I'm Brandon Olenski, airline and transport analyst.
Next up, we have, RXO, and joining us from the company is Jared Weisfeld, Chief Strategy Officer, and Kevin Starling, senior market strategist, head of IR, and before we get into this, we'll just do the audience response questions really quick. I'm sure if you guys have been through a fireside, just pick up that little remote there. Sorry Kevin, we don't have one for you, but if you can queue up, question number one please.
Do you currently own RXO yes, overweight, market weight, 3 underweight, or 4? No. You can go ahead and vote. Appreciate everyone, participating too.
Okay, and then question number 2.
What is your general bias towards RXO right now, positive, negative, or neutral?
All right, and then question number 3, please.
In your opinion, through cycle EPOs growth for RXO will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
